Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Understand how tax efficiency varies among total market funds, and what factors influence after-tax returns for retirement investing.
28,571 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Bitcoin reclaims $63,000 as a relief rally emerges from oversold conditions, while South Korea's KOSPI drops 8% on te...
A wave of new positions from hedge funds loading boeing points to a cautious but growing bet that Boeing can rebound ...
A reported breakthrough on Iran negotiations sparked a risk-on market rally and shifted bets on the Federal Reserve's...
Northcoast downgraded Norwegian Cruise Line amid macro headwinds, signaling tougher times for the sector as Middle Ea...
Netflix faces a shifting market environment even as its ad-supported push gains momentum. This piece weighs the buy, ...
Solana is trading near $97 as traders weigh a potential move above $100 this month. Analysts point to ETF demand and ...
After a string of near-misses, Netflix finally makes acquisition that seems to align with its long-term plan. This pi...
A veteran journalist outlines Elliott Investment Management’s influence on Norwegian Cruise Line amid a strong cruise...
Investing in niche space stocks can be volatile. This analysis breaks down why gilat satellite networks stock dropped...
NovaCore Technologies enters the second half of 2026 with a multi-year backlog, AI revenue momentum, and cloud growth...
GLPI's Q4 2025 results show growth, margin trends, and clearer guidance for 2026. This analysis translates the number...